Nepean Urology Research Group, Nepean Hospital, Kingswood, Australia.
Faculty of Medicine, University of Queensland, Queensland, Australia.
J Endourol. 2020 Apr;34(4):401-408. doi: 10.1089/end.2019.0554. Epub 2020 Mar 23.
To perform a systematic review and meta-analysis and to assess the clinical benefit of prophylactic pelvic drain (PD) placement after robot-assisted laparoscopic prostatectomy (RALP) with pelvic lymph node dissection (PLND) in patients with localized prostate cancer. An electronic search of databases, including Scopus, Medline, and EMbase, was conducted for articles that considered postoperative outcomes with PD placement and without PD (no drain) placement after RALP. The primary outcome was rate of symptomatic lymphocele (requiring intervention) and secondary outcomes were complications as described by the Clavien-Dindo classification system. Quality assessment was performed using the Modified Cochrane Risk of Bias Tool for Quality Assessment. Six relevant articles comprising 1783 patients (PD = 1253; ND = 530) were included. Use of PD conferred no difference in symptomatic lymphocoele rate (risk difference 0.01; 95% confidence interval [CI] -0.007 to 0.027), with an overall incidence of 2.2% (95% CI 0.013-0.032). No difference in low-grade (I-II; risk difference 0.035, 95% CI -0.065 to 0.148) or high-grade (III-V; risk difference -0.003, 95% CI -0.05 to 0.044) complications was observed between PD and ND groups. Low-grade (I-II) complications were 11.8% (95% CI 0-0.42) and 7.3% (95% CI 0-0.26), with similar rates of high-grade (III-V) complications, being 4.1% (95% CI 0.008-0.084) and 4.3% (95% CI 0.007-0.067) for PD and ND groups, respectively. PD insertion after RALP with extended PLND did not confer significant benefits in prevention of symptomatic lymphocoele or postoperative complications. Based on these results, PD insertion may be safely omitted in uncomplicated cases after consideration of clinical factors.
进行系统评价和荟萃分析,评估在机器人辅助腹腔镜前列腺切除术(RALP)联合盆腔淋巴结清扫术(PLND)治疗局限性前列腺癌患者中预防性放置盆腔引流管(PD)的临床获益。对包括 Scopus、Medline 和 EMbase 在内的数据库进行电子检索,以获取考虑 PD 放置和不放置 PD(无引流)对 RALP 术后结局影响的文章。主要结局是有症状的淋巴囊肿(需要干预)的发生率,次要结局是根据 Clavien-Dindo 分类系统描述的并发症。使用改良 Cochrane 偏倚风险工具进行质量评估。共纳入 6 篇相关文章,共纳入 1783 例患者(PD=1253 例;ND=530 例)。使用 PD 并未降低有症状的淋巴囊肿发生率(风险差异 0.01;95%置信区间[CI] -0.007 至 0.027),总体发生率为 2.2%(95% CI 0.013 至 0.032)。PD 组和 ND 组之间在低级别(I-II;风险差异 0.035,95% CI -0.065 至 0.148)或高级别(III-V;风险差异 -0.003,95% CI -0.05 至 0.044)并发症方面无差异。低级别(I-II)并发症发生率分别为 11.8%(95% CI 0 至 0.42)和 7.3%(95% CI 0 至 0.26),高级别(III-V)并发症发生率相似,分别为 4.1%(95% CI 0.008 至 0.084)和 4.3%(95% CI 0.007 至 0.067)。RALP 联合广泛 PLND 后放置 PD 并不能显著预防有症状的淋巴囊肿或术后并发症。基于这些结果,在考虑临床因素后,在无并发症的情况下,PD 放置可安全省略。